Obesity confers chemotherapy resistance in triple negative breast cancer cells

被引：1
|
作者：
Lehrmann, Victoria R. [1 ]
Bowers, Laura W. [1 ]
Brenner, Andrew J. [1 ]
Degraffenried, Linda A. [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr, San Antonio, TX USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P5-05-13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-05-13
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Lipid accumulation in residual triple negative breast cancer cells surviving chemotherapy treatment
    Pendleton, Katherine E.
    Baek, Mokryun L.
    Lee, Junegoo
    Tan, Lin
    Johnson, Hannah L.
    Dobrolecki, Lacey E.
    Barrish, James P.
    Lewis, Michael T.
    Lorenzi, Philip L.
    Stossi, Fabio
    Echeverria, Gloria V.
    CANCER RESEARCH, 2023, 83 (05)
  • [42] CLDN1 Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy
    Lemesle, Marine
    Geoffroy, Marine
    Alpy, Fabien
    Tomasetto, Catherine-Laure
    Kuntz, Sandra
    Grillier-Vuissoz, Isabelle
    CANCERS, 2022, 14 (20)
  • [43] Transcriptome changes of immune cells across chemotherapy of triple-negative breast cancer
    Gerashchenko, T. S.
    Frolova, A.
    Fedorov, A. A.
    Patysheva, M.
    Vashisth, M.
    Iamshchikov, P.
    Bragina, O.
    Cherdyntseva, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S214 - S214
  • [44] The effectiveness of autophagy inhibition in sensitizing triple-negative breast cancer cells to chemotherapy
    Bortnik, Svetlana
    Chittaranjan, Suganthi
    Xu, Jing
    Dragowska, Wieslawa H.
    An, Jianghong
    Kyle, Adrienne
    Go, Nancy E.
    Vezenkov, Lubomir
    Choutka, Courtney
    Leung, Amy
    Kovacic, Suzana
    Bosc, Damien
    Gelmon, Karen
    Bally, Marcel
    Jones, Steven
    Young, Robert
    Gorski, Sharon
    CANCER RESEARCH, 2015, 75
  • [45] CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer
    Deng, Xinyu
    Apple, Sophia
    Zhao, Hong
    Song, Jeongyoon
    Lee, Minna
    Luo, William
    Wu, Xiancheng
    Chung, Debra
    Pietras, Richard J.
    Chang, Helena R.
    ONCOTARGET, 2017, 8 (24) : 38294 - 38308
  • [46] Overcoming chemotherapy resistance in triple negative breast cancer via targeting lysyl oxidase (LOX)
    Saatci, Ozge
    Akbulut, Ozge
    Rezaeain, Abdol-Hossein
    Banister, Carolyn
    Sikirzhytski, Vitali
    Aksoy, Sercan
    Akyol, Aytekin
    Uner, Aysegul
    Buckhaults, Phillip
    Chernov, Mikhail
    McInnes, Campbell
    Riazalhosseini, Yasser
    Sahin, Ozgur
    CANCER RESEARCH, 2021, 81 (05)
  • [47] AHNAK nucleoprotein 2 tune oxidative stress and resistance to chemotherapy in triple negative breast cancer
    Hao, Na
    CANCER RESEARCH, 2024, 84 (06)
  • [48] Plasma CAMK2A predicts chemotherapy resistance in metastatic triple negative breast cancer
    Shao, Bin
    Tian, Zhihua
    Ding, Huirong
    Wang, Qingsong
    Song, Guohong
    Di, Lijun
    Zhang, Hong
    Li, Huiping
    Shen, Jing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (02): : 650 - 663
  • [49] TRIPLE NEGATIVE ADVANCED BREAST CANCER: BIOLOGY AND RESISTANCE
    Curigliano, Giuseppe
    BREAST, 2019, 48 : S25 - S25
  • [50] SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer
    Liu, Xi-Yu
    Jiang, Wang
    Ma, Ding
    Ge, Li-Ping
    Yang, Yun-Song
    Gou, Zong-Chao
    Xu, Xiao-En
    Shao, Zhi-Ming
    Jiang, Yi-Zhou
    THERANOSTICS, 2020, 10 (24): : 10940 - 10956
12345